I

Inno-Gene SA
WSE:IGN

Watchlist Manager
Inno-Gene SA
WSE:IGN
Watchlist
Price: 5.04 PLN -0.4% Market Closed
Market Cap: 17.7m PLN
Have any thoughts about
Inno-Gene SA?
Write Note

Inno-Gene SA
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Inno-Gene SA
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
I
Inno-Gene SA
WSE:IGN
Cash from Operating Activities
-zł948k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
9%
M
Medicofarma Biotech SA
WSE:MDB
Cash from Operating Activities
zł4.8k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
R
Ryvu Therapeutics SA
WSE:RVU
Cash from Operating Activities
-zł121m
CAGR 3-Years
-28%
CAGR 5-Years
-26%
CAGR 10-Years
-35%
S
Selvita SA
WSE:SLV
Cash from Operating Activities
zł76.7m
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Inno-Gene SA
Glance View

Market Cap
17.7m PLN
Industry
Life Sciences Tools & Services

Inno Gene SA engages in the management of startup biotechnology companies. The company is headquartered in Poznan, Woj. Wielkopolskie. The company went IPO on 2011-02-08. Inno-Gene SA’s portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology. On March 22, 2013, the Company established a new subsidiary, Centrum Edukacji Bio-Medycznej Sp. z o.o. On April 11, 2013, the Company established two new indirect subsidiaries, Genomix Sp. z o.o. and Madgenetix Sp. z o.o. In addition, it operates through VitainSillica Sp z o o.

IGN Intrinsic Value
2.03 PLN
Overvaluation 60%
Intrinsic Value
Price
I

See Also

What is Inno-Gene SA's Cash from Operating Activities?
Cash from Operating Activities
-948k PLN

Based on the financial report for Jun 30, 2024, Inno-Gene SA's Cash from Operating Activities amounts to -948k PLN.

What is Inno-Gene SA's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
9%

Over the last year, the Cash from Operating Activities growth was 82%.

Back to Top